---
schema_version: "secwatch.filing_event.v1"
accession: "0001808220-24-000008"
form_type: "8-K"
ticker: "GOCO"
cik: "0001808220"
company_name: "GoHealth, Inc."
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T21:28:42.977939+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GoHealth reports FY2023 cash from ops up 79% to $109.1M; Q4 rev $276.7M

## Summary
- Q4 2023 net revenue $276.7M vs $69.4M YoY; full-year $734.7M vs $631.7M.
- Q4 net loss improved 98.5% to $2.3M; Adjusted EBITDA $57.0M (up 160%).
- Full-year net loss of $151.3M improved 59.8%; Adjusted EBITDA $75.1M (up 158%).
- Non-agency Medicare revenue reached 60% of total in Q4, up from 26% in 2022.
- No Lookback adjustment in 2023; Company assisted over 2M Medicare consumers.

## SEC filing metadata
- accession: 0001808220-24-000008
- form_type: 8-K
- ticker: GOCO
- cik: 0001808220
- company_name: GoHealth, Inc.
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808220/000180822024000008/0001808220-24-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808220/000180822024000008/goco-20240314.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808220-24-000008
- JSON: https://secwatch.observer/filing/0001808220-24-000008.json
- Plain text: https://secwatch.observer/filing/0001808220-24-000008.txt

## Key facts
- Earnings Releases
  GoHealth, Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue $276.7 million, net income net loss was $2.3 million.
  - Period: the fourth quarter and year ended December 31, 2023
  - Revenue: $276.7 million
  - Net income: net loss was $2.3 million
  - Result: reported results
  source text: Fourth quarter 2023 net revenues were $276.7 million, compared to $69.4 million in the prior year period. Full year 2023 net revenues were $734.7 million, compared to $631.7 million in 2022. • Fourth quarter 2023 net loss was $2.3 million and Adjusted EBITDA 1 was $57.0 million, improvements of 98.5% and 160.1%, respectively, compared to the prior year period. Full year 2023 net loss of $151.3 million and Adjusted EBITDA 1 of $75.1 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808220/000180822024000008/0001808220-24-000008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.